About 8 results found for searched term "80-49-9" (0.052 seconds)
Cat.No. | Name | Target |
---|---|---|
M2758 | Homatropine Methylbromide | AChR/AChE |
Homatropine methobromide | ||
Homatropine Methylbromide is muscarinic AChR antagonist, inhibits endothelial and smooth muscle muscarinic receptors of WKY-E and SHR-E with IC50 of 162.5 nM and 170.3 nM, respectively. | ||
M5059 | Furafylline | Cytochrome P450 (e.g. CYP17) |
Furafylline was a potent, non-competitive inhibitor of high affinity phenacetin O-deethylase activity of microsomal fractions of human liver, a reaction catalysed by P450IA2, with an IC50 value of 0.07 microM. | ||
M5245 | Olodaterol | Adrenergic Receptor |
BI1744 | ||
Olodaterol (BI1744) is a selective, long acting β2-adrenoceptor (β2-AR) agonist (EC50=0.1 nM and pKi= 9.14 for human β2-adrenoceptor, respectively). Olodaterol can be used for chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis. | ||
M6363 | A-286982 | Integrin |
A286982 | ||
A-286982 is a potent inhibitor of the LFA-1/ICAM-1 interaction. A-286982 binds to the I domain allosteric site (IDAS). | ||
M6730 | Filipin III | Antibiotic |
Filipin III is a polyene antibiotic; inhibits formation of PrPSc. | ||
M21008 | Bismuth Subcitrate Potassium | Antibiotic |
Bismuth Subcitrate is an antibiotic used to treat stomach ulcers associated with Helicobacter pylori, a bacterial infection. | ||
M24814 | Valziflocept | Others |
BAX1810; TAK-752 | ||
Valziflocept (BAX1810; TAK-752) is a recombinant soluble human FcγRIIb receptor that targets Fc and FcγR. FcγRs bind and neutralize pathogenic IgG, thus forming a "decoy" or "scavenger" receptor that can reduce the severity of autoimmune diseases. Valziflocept can be used in studies of autoimmune diseases such as systemic lupus erythematosus (SLE). | ||
M56951 | FAM alkyne, 6-isomer | Others |
FAM alkyne, 6-isomer is a click chemistry regent that can be used in 1,3-dipolar cycloaddition with azido-labeled compound. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.